简
/
繁
/
EN
About Us
R&D
Products
News
Careers
Investors
Contact us
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
27
2023-08
Announcement of Interim Results for the Six Months Ended 30 June 2023
16
2023-08
Notice of Board Meeting
01
2023-08
Articles of Association
01
2023-08
Voluntary Announcement Amendments to the Articles of Association
01
2023-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
03
2023-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
01
2023-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
29
2023-05
Articles of Association
29
2023-05
Poll Results of the Annual General Meeting Held on 29 May 2023
16
2023-05
Voluntary Announcement Approval Obtained for Initiating Clinical Trial for the Novel Bispecific Antibody BA1202 in China
8
9
10
11
12
Follow me
鲁公网安备37069102000284